STOCK TITAN

DarioHealth (DRIO) director reports owning 4,500 common shares

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

DarioHealth Corp. director John R. Palumbo has filed an initial Form 3 stating beneficial ownership of 4,500 shares of DarioHealth common stock held directly. This filing reports his starting equity position as a director and does not reflect any recent share purchases or sales.

Positive

  • None.

Negative

  • None.
Insider PALUMBO JOHN R
Role Director
Type Security Shares Price Value
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 4,500 shares (Direct)
Common stock holdings 4,500 shares Beneficial ownership reported on Form 3
Form 3 regulatory
"John R. Palumbo has filed an initial Form 3 stating ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"The Form 3 states his beneficial ownership of 4,500 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Common Stock financial
"He is reported as holding 4,500 shares of Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the DarioHealth (DRIO) Form 3 filed by John R. Palumbo show?

The Form 3 shows that director John R. Palumbo beneficially owns 4,500 shares of DarioHealth common stock held directly. This is an initial ownership report, not a record of new share purchases or sales.

How many DarioHealth (DRIO) shares does director John R. Palumbo hold?

Director John R. Palumbo is reported as beneficially owning 4,500 shares of DarioHealth common stock. These shares are listed as directly owned and represent his disclosed equity position in the company at the time of the Form 3 filing.

Does the DarioHealth (DRIO) Form 3 indicate any recent insider buying or selling?

No, the Form 3 for DarioHealth director John R. Palumbo does not indicate any recent buying or selling. It simply discloses his existing direct ownership of 4,500 common shares as an initial beneficial ownership statement.

Is John R. Palumbo a director or officer of DarioHealth (DRIO) in this Form 3?

In this Form 3, John R. Palumbo is identified as a director of DarioHealth Corp. He is not listed as an officer and reports direct beneficial ownership of 4,500 shares of common stock in the company.

What type of security does John R. Palumbo report owning in DarioHealth (DRIO)?

John R. Palumbo reports beneficial ownership of Common Stock of DarioHealth Corp. The Form 3 states that he directly holds 4,500 shares of this common stock, with no derivative securities disclosed in the filing data provided.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
PALUMBO JOHN R

(Last)(First)(Middle)
322 W 57TH ST, #33B

(Street)
NEW YORK NEW YORK 10019

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/10/2026
3. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock4,500D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ John R. Palumbo04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)